Risedronate induced transient ocular myasthenia.
Raja
V
V
Sandanshiv
P
P
Neugebauer
M
M
D000369:Aged, 80 and over; D001763:Blepharoptosis / Q000139:chemically induced; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D012968:Etidronic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000139:chemically induced*; D000068296:Risedronic Acid
D050071:Bone Density Conservation Agents; D000068296:Risedronic Acid; D012968:Etidronic Acid